Abstract
Hepatotoxicity has been observed with several chemotherapy agents and combination regimens. Conventional treatment methods often include supportive care or observation. We report a case of a patient with noted transaminitis presumed secondary to chemotherapy, which did not resolve with supportive care but was shown to respond to milk thistle. The patient had an immediate decrease in liver function tests and showed decreased elevation in levels upon treatment with subsequent chemotherapy regimens. This case demonstrates the potential efficacy of milk thistle as a unique hepatoprotective agent.
Original language | English |
---|---|
Pages (from-to) | 360-365 |
Number of pages | 6 |
Journal | Journal of Oncology Pharmacy Practice |
Volume | 18 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2012 |
Keywords
- Milk thistle
- chemotherapy
- silybin
- silymarin
- transaminitis